FDA Inspection
Octapharma Plasma IncOctapharma Plasma Inc – FDA Inspection, Jul 10, 2026
Record Details
This FDA Inspection record concerns Octapharma Plasma Inc, with an inspection on July 10, 2026, issued by the New Jersey District Office, covering biologics.
View Company Profile
ID · e00e4431-7140-48fe-841b-189d5fcd5fe4
Inspection Facts
- Inspection number
- 1327022
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.20(b)Qualifications of responsible personnel
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2023 | Not classified | New Jersey District Office |
Other documents for Octapharma Plasma Inc
- FDA Inspection 1214337 - 2023-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.